Tumor-extrinsic discoidin domain receptor 1 promotes mammary tumor growth by regulating adipose stromal interleukin 6 production in mice

被引:21
|
作者
Sun, Xiujie [1 ]
Gupta, Kshama [1 ]
Wu, Bogang [1 ]
Zhang, Deyi [1 ]
Yuan, Bin [1 ]
Zhang, Xiaowen [1 ]
Chiang, Huai-Chin [1 ]
Zhang, Chi [1 ]
Curiel, Tyler J. [1 ]
Bendeck, Michelle P. [2 ]
Hursting, Stephen [3 ]
Hu, Yanfen [1 ]
Li, Rong [1 ]
机构
[1] Univ Texas Hlth San Antonio, Dept Med, Dept Mol Med, San Antonio, TX 78229 USA
[2] Univ Toronto, Ted Rogers Ctr Heart Res, Toronto, ON M5G 1M1, Canada
[3] Univ N Carolina, Nutr Res Inst, Dept Nutr, Chapel Hill, NC 27599 USA
基金
美国国家卫生研究院;
关键词
BREAST-CANCER CELLS; MESENCHYMAL TRANSITION; TYROSINE KINASES; CLAUDIN-LOW; BASAL-LIKE; OBESITY; INFLAMMATION; PROGRESSION; EXPRESSION; TISSUE;
D O I
10.1074/jbc.RA117.000672
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Discoidin domain receptor 1 (DDR1) is a collagen receptor that mediates cell communication with the extracellular matrix (ECM). Aberrant expression and activity of DDR1 in tumor cells are known to promote tumor growth. Although elevated DDR1 levels in the stroma of breast tumors are associated with poor patient outcome, a causal role for tumor-extrinsic DDR1 in cancer promotion remains unclear. Here we report that murine mammary tumor cells transplanted to syngeneic recipient mice in which Ddr1 has been knocked out (KO) grow less robustly than in WT mice. We also found that the tumor-associated stroma in Ddr1-KO mice exhibits reduced collagen deposition compared with the WT controls, supporting a role for stromal DDR1 in ECM remodeling of the tumor microenvironment. Furthermore, the stromal-vascular fraction (SVF) of Ddr1 knockout adipose tissue, which contains committed adipose stem/progenitor cells and preadipocytes, was impaired in its ability to stimulate tumor cell migration and invasion. Cytokine array-based screening identified interleukin 6 (IL-6) as a cytokine secreted by the SVF in a DDR1-dependent manner. SVF-produced IL-6 is important for SVF-stimulated tumor cell invasion in vitro, and, using antibody-based neutralization, we show that tumor promotion by IL-6 in vivo requires DDR1. In conclusion, our work demonstrates a previously unrecognized function of DDR1 in promoting tumor growth.
引用
收藏
页码:2841 / 2849
页数:9
相关论文
共 47 条
  • [41] Intracerebroventricular injection of anti-Fas activates the hypothalamus-pituitary-adrenal axis and induces peripheral interleukin-6 and serum amyloid A in mice - Comparison with other ligands of the tumor necrosis factor nerve growth factor receptor superfamily
    Benigni, F
    Sacco, S
    Aloe, L
    Ghezzi, P
    AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (05): : 1377 - 1381
  • [42] In Vivo Anticancer Evaluation of 6b, a Non-Covalent Imidazo[1,2-a]quinoxaline-Based Epidermal Growth Factor Receptor Inhibitor against Human Xenograft Tumor in Nude Mice
    Bhat, Zahid Rafiq
    Kumar, Manvendra
    Sharma, Nisha
    Yadav, Umesh Prasad
    Singh, Tashvinder
    Joshi, Gaurav
    Pujala, Brahmam
    Raja, Mohd
    Chatterjee, Joydeep
    Tikoo, Kulbhushan
    Singh, Sandeep
    Kumar, Raj
    MOLECULES, 2022, 27 (17):
  • [43] CD1d-restricted natural killer T cells can down-regulate tumor immunosurveillance independent of interleukin-4 receptor-signal transducer and activator of transcription 6 or transforming growth factor-β
    Terabe, M
    Khanna, C
    Bose, S
    Melchionda, F
    Mendoza, A
    Mackall, CL
    Helman, LJ
    Berzofsky, JA
    CANCER RESEARCH, 2006, 66 (07) : 3869 - 3875
  • [44] Long Non-Coding RNAs (lncRNAs) Tumor-Suppressive Role of lncRNA on Chromosome 8p12 (TSLNC8) Inhibits Tumor Metastasis and Promotes Apoptosis by Regulating Interleukin 6 (IL-6)/Signal Transducer and Activator of Transcription 3 (STAT3)/Hypoxia-Inducible Factor 1-alpha (HIF-1α) Signaling Pathway in Non-Small Cell Lung Cancer
    Fan, Hanli
    Li, Jianbo
    Wang, Jiwu
    Hu, Zange
    MEDICAL SCIENCE MONITOR, 2019, 25 : 7624 - 7633
  • [45] Iguratimod suppresses sclerostin and receptor activator of NF-KB ligand production via the extracellular signal-regulated kinase/early growth response protein 1/tumor necrosis factor alpha pathway in osteocytes and ameliorates disuse osteoporosis in mice
    Miura, Taihei
    Etani, Yuki
    Noguchi, Takaaki
    Hirao, Makoto
    Takami, Kenji
    Goshima, Atsushi
    Kurihara, Takuya
    Fukuda, Yuji
    Ochiai, Nagahiro
    Kanamoto, Takashi
    Nakata, Ken
    Okada, Seiji
    Ebina, Kosuke
    BONE, 2024, 181
  • [46] Serum interleukin-6 (IL-6), IL-10, tumor necrosis factor (TNF) alpha, soluble type II TNF receptor, and transforming growth factor beta levels in human immunodeficiency virus type 1-infected individuals with Mycobacterium avium complex disease
    Havlir, DV
    Torriani, FJ
    Schrier, RD
    Huang, JY
    Lederman, MM
    Chervenak, KA
    Boom, WH
    JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (01) : 298 - 303
  • [47] Targeting heat shock protein 90 in pancreatic cancer impairs insulin-like growth factor-I receptor signaling, disrupts an interleukin-6/signal-transducer and activator of transcription 3/hypoxia-inducible factor-1α autocrine loop, and reduces orthotopic tumor growth
    Lang, Sven A.
    Moser, Christian
    Gaumann, Andreas
    Klein, Dagmar
    Glockzin, Gabriel
    Popp, Felix C.
    Dahlke, Marc H.
    Piso, Pompiliu
    Schlitt, Hans J.
    Geissler, Edward K.
    Stoeltzing, Oliver
    CLINICAL CANCER RESEARCH, 2007, 13 (21) : 6459 - 6468